Motivated by these analyses we further investigated the conjoint presence of the SLex glycan structure with CEA in gastric carcinoma tissues and determine how well such a dual signature associates with clinicopathological features of the cases and patients' prognosis. This evidence concerns the gene CEACAM5 and gastric carcinoma.